G. Patrick Lynch to the position of President and Chief Operating Officer of the Company. Mr. G. Patrick Lynch previously served as President of North American Operations for NTI, a position he had held since May 2004. Mr. Patrick Lynch has been serving NTI since 1995 in successive management functions. Prior to joining NTI, Mr. G. Patrick Lynch held positions with Fuji Electric Co., Ltd in Tokyo, Japan, and BMW AG in Munich, Germany. Mr. G. Patrick Lynch received an M.B.A. degree from the University of Michigan Business School in Ann Arbor, Michigan.
NTI also announced that Mr. G. Patrick Lynch's predecessor, Mr. Mehmet A. Gencer, has entered into an agreement with the Company to serve as an independent advisor in order to bring certain new technologies to fruition.
NTI also announced that Mr. Philip M. Lynch has withdrawn as Chairman of the Board of Directors and Chief Executive Officer of the company, effective as of July 29, 2005. Mr. Philip M. Lynch will retain the title of Chairman Emeritus, and will continue to serve the company in the development of special projects.
NTI also announced the election of Mr. Pierre Chenu, a current Director of the company, as non-executive Chairman of the Board. Mr. Chenu previously served as Vice President, Worldwide Operations, Flat Glass Activities within the Asahi-Glaverbel Glass Group. Mr. Chenu holds a Master's Degree in Engineering, with a specialty in metallurgy, from the University of Liege (Belgium) and an M.B.A. from Harvard University.
NTI also announced the election and appointment of Mr. Jean-Guy Joseph Coulombe and Ms. Vera Kallmeyer to the company's Board of Directors. Mr. Coulombe is President of Metso Minerals Company. Mr. Coulombe previously served in an engineering capacity at Outokumpu Technology from 2002 to 2004. From 1989 to 2002, Mr. Coulombe was in the equipment manufacturing division of Sandvik Mining & Construction Company.
Ms. Kallmeyer currently serves as Managing Partner of Equity4Health LLC, a financial and investment management and consulting firm she founded in 2002. Ms. Kallmeyer also serves as a Consulting Professor at Stanford School of Medicine, Department of Neurosurgery, where she teaches classes in entrepreneurship and company formation. From 1998 to 2002, Ms. Kallmeyer served as Managing Partner of Veritas Venture Partners LLC, a financial and investment management and consulting firm. From 1994 to 1998, she served as Chief Financial Officer and Vice President of Corporate Development of Aviron Inc., a NASDAQ listed biopharmaceutical company that was subsequently acquired by MedImmune, Inc.